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1Angiotensin II-mediated expression of p27Kip1 and induction of
cellular hypertrophy in renal tubular cells depend on the gener-
ation of oxygen radicals.
Background. Angiotensin II (Ang II) induces hypertrophy of
cultured proximal tubular cells. We have previously demonstrated
that this Ang II-mediated hypertrophy occurs in the G1-phase of
the cell cycle and depends on the induction of p27Kip1, an
inhibitor of G1-phase cyclin/cyclin-dependent kinase complexes.
The present study was undertaken to investigate whether Ang II
may stimulate superoxide anions (O2
•) formation in cultured
LLC-PK1 and cultured mouse proximal tubule (MCT) cells, and
to gain further insight into a potential relationship between O2
•
and cell cycle regulation.
Methods. Reactive oxygen species were measured with the
lucigenin method in intact cells. The effects of various inhibitors
were tested on Ang II-induced O2
• production. Cells were
transiently transfected with phosphorothioate-modified rat
p22phox antisense oligonucleotides to investigate the potential
role of NAD(P)H oxidase. Expression of p22phox mRNA after
Ang II-treatment was detected with Northern blots. Incorporation
of [3H]leucine into de novo synthesized proteins was used as a
parameter of cell hypertrophy. Expression of p27Kip1 was evalu-
ated in cell lysates by Western blotting.
Results. Ang II stimulated the accumulation of O2
• in tubular
cells; however, an addition of two different antioxidants com-
pletely abolished measurable O2
•. This effect was transduced by
angiotensin receptor type-1 (AT1) and was inhibited by a fla-
voprotein inhibitor (DIP) or p22phox antisense oligonucleotides,
indicating the involvement of membrane NAD(P)H oxidase. Ang
II-stimulated de novo protein synthesis was attenuated by DIP,
antioxidants, and p22phox antisense oligonucleotides. The Ang
II-induced expression of p27Kip1 protein and cellular hypertrophy
were reduced by similar treatments. Generation of O2
• by xan-
thine supplementation also stimulated p27Kip1 expression and
induced hypertrophy in LLC-PK1 cells.
Conclusion. This study provides the first evidence, to our
knowledge, that Ang II induces O2
• in cultured tubular cells. Ang
II-mediated activation of membrane bound NAD(P)H oxidase,
probably by an increase in p22phox transcripts, is likely responsi-
ble for this induction. Generation of O2
• subsequently induces
p27Kip1 expression and stimulates hypertrophy, suggesting a novel
mechanism of how Ang II can modulate cell cycle regulation.
Chronic renal injury leads to tubular hypertrophy with an
increase in tubular size and protein content without repli-
cation of DNA [1]. Although such a hypertrophy of surviv-
ing tubules can be initially considered as a process to
compensate for the chronic destruction of surrounding
nephrons, there is some evidence that the cellular processes
of tubular hypertrophy may themselves contribute to fur-
ther injury of renal tissue, leading eventually to tubuloin-
terstitial fibrosis [2]. Several growth factors and hormones
can modify, if not induce, renal tubular hypertrophy [1]. We
have previously shown that angiotensin II (Ang II), as a
single factor, stimulates hypertrophy of cultured mouse
proximal tubular cell (MCT cells) as well as of LLC-PK1
cells, a porcine cell line with some properties of proximal
tubules [3, 4]. Other investigators have subsequently con-
firmed these findings in primary cultures of proximal
tubular cells obtained from various species [5–7]. Ang
II-treated proximal tubular cells actively enter the cell cycle
from the G0-phase [3]. However, these cells do not progress
further towards the S-phase and remain arrested in the
G1-phase of the cell cycle where they undergo hypertrophy
[3]. Since progression through the cell cycle is controlled by
a series of cyclin and cyclin-dependent kinase (CdK) com-
plexes that may be inactivated by CdK inhibitors such as
p27Kip1, we recently investigated whether Ang II may
influence the expression of p27Kip1 in LLC-PK1 cells [8].
These studies demonstrated that Ang II treatment en-
hanced p27Kip1 protein, but not mRNA expression [8].
Immunoprecipitation experiments revealed that the in-
duced p27Kip1 protein associates with CdK4 and inhibits its
kinase activity. Finally, treatment of LLC-PK1 cells with
p27Kip1 antisense, but not missense, oligonucleotides abol-
ished the Ang II-mediated cell hypertrophy. This provided
1 See Editorial by Shankland, p. 2241.
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functional evidence that this CdK-inhibitor plays an essen-
tial role in the Ang II-mediated hypertrophy of proximal
tubular cells [8]. However, it remains unclear which signal
transduction pathway is employed by Ang II after binding
to AT1-receptors, and how putative second messengers may
interact with the regulation of the cell cycle.
Recent studies in cultured vascular smooth muscle cells
(VSMC) provided convincing evidence that Ang II stimu-
lates NAD(P)H oxidase leading to an increase in intracel-
lular superoxide anion (O2
•) formation [9]. In addition,
interference with the Ang II-mediated generation of such
active oxygen species, for example, by antioxidants or
inhibitors of flavoproteins, abolished VSMC hypertrophy
[9]. The present study was undertaken to test whether
similar mechanisms may be operative in the process of Ang
II-mediated hypertrophy of renal proximal tubular cells,
and to gain information about whether oxygen intermedi-
ates may influence the expression of p27Kip1.
METHODS
Cell culture
Cultured mouse proximal tubule (MCT) cells are a
proximal tubular cell line originally isolated from SJL mice
[10] that have been widely used and are characterized in
great detail [10]. LLC-PK1 cells are a permanent, well-
characterized proximal tubular cell line from the pig that
also expresses some properties of cells from the distal
nephron [11]. Both cell lines were grown in Dulbecco’s
modified Eagle’s medium (DMEM with 450 mg/dl D-
glucose; Gibco, Eggenstein, Germany) supplemented with
100 units/ml penicillin, 100 mg/ml streptomycin, and 10%
heat-inactivated fetal calf serum (Gibco). Cells were cul-
tured at 37°C in 5% CO2 and were passaged every three to
five days by light trypsination. In general, for the measure-
ments of the various parameters, cells were rested for 24
hours in serum-free DMEM, and subsequent stimulation
with Ang II was also performed in serum-free medium.
Measurement of O2
• generation in intact cells
The lucigenin method was used to measure O2
• produc-
tion in intact cells. Cells, rested for 24 hours in serum-free
medium, were stimulated for four hours with a single dose
of 1027 M Ang II (Sigma, Deisenhofen, Germany). This
dose was selected because previous studies have demon-
strated that this concentration readily induced hypertrophy
of proximal tubular cells [3, 4, 12]. To control for the
specificity of the response, cells were also co-incubated with
1026 M of either the AT1-receptor blocker losartan (gift of
MSD, Munich, Germany) or the AT2-antagonist PD
123177 (gift of Parke-Davis, Warner Lambert Co., Ann
Arbor, MI, USA). Additional cells were also co-incubated
with Ang II and 5 to 10 mM of the flavoprotein inhibitor
diphenylene iodinium (DIP). Some cells received 5 to 10
mM of the antioxidant N-acetylcysteine (NAC) five minutes
prior O2
• measurement. To test the specificity of the assay,
10 mM of the nonenzymatic O2
• scavenger Tiron (4,5
dihydroxy-1,3-benzene disulfonic acid salt; Sigma) was
added during the continuous measurement of O2
• release.
To gain insight whether interference with the expression
of NAD(P)H oxidase may modulate Ang II-stimulated O2
•
generation, transient transfection with phosphorothioate-
modified rat p22phox, the a-subunit of cytochrome b-558,
antisense or sense oligonucleotides was performed. The




For these experiments, cells were rested for 12 hours in
serum-free medium, and then transfected with 1 mM oligo-
nucleotides using lipofectiny reagent (Gibco) as recom-
mended by the manufacturer. The medium was subse-
quently changed and transfected cells were stimulated for
four hours with Ang II.
Finally, 5 to 10 mM xanthine (Sigma) with and without 0.5
units/ml superoxide dismutase (SOD; Sigma) were added
to LLC-PK1 cells to induce reactive oxygen species in the
absence of Ang II.
After incubation, cells were shortly trypsinated, collected
by centrifugation, and the pellet was washed in a modified
Krebs buffer containing (in mM):NaCl 130, KCl 5, MgCl2 1,
CaCl2 1.5, K2HPO4 1, HEPES 20, pH 7.4. After washing,
cells were resuspended in Krebs buffer with 10 mM glucose
and 1 mg/ml bovine serum albumin (BSA), and cell con-
centration was adjusted to 5 3 106 in 900 ml buffer. To
measure O2
• production, this cell suspension was trans-
ferred into a cuvette in a luminometer (LB 9501; Berthold,
Bad Wildbad, Germany), and measurement was started by
an injection of 100 ml lucigenin (Sigma) in Krebs buffer
(final concentration of lucigenin 5 3 1024 M). Photon
emission was counted every 15 seconds for up to 15
minutes. A buffer blank (reaction buffer with lucigenin, but
without cells, which was always ,5% of the signal in the
presence of cells) was subtracted from each reading. To
calculate the amount of O2
• produced, a standard curve
with xanthine/xanthine oxidase was generated as previously
described [9], and the time point at 10 minutes was arbitrarily
selected to convert relative light units into nM O2
•.
[3H]leucine incorporation
We have previously shown that de novo protein synthesis
as measured by [3H]leucine incorporation correlates closely
with other parameters of cellular hypertrophy [3, 4, 12].
Therefore, [3H]leucine incorporation was used as a param-
eter of proximal tubular hypertrophy. Cells were plated
(105 per well) in 24-well plates, made quiescent for 24 hours
in serum-free medium, and then stimulated for another 24
hours with 1027 M Ang II in the presence or absence of 10
mM DIP or NAC. Some cells were also treated with 1 to 10
mM xanthine redissolved in serum-free medium. For the last
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12 hours of this stimulation, cells were pulsed with 5 mCi
[3H]leucine (142 Ci/mmol; Amersham, Braunschweig, Ger-
many). The cells were washed three times in ice-cold PBS
and were then precipitated twice with 10% trichloroacetic
acid on ice. Proteins were redissolved in 0.5 M NaOH
containing 0.1% Triton X-100, and radioactivity was mea-
sured by liquid scintillation spectroscopy after adding 5 ml
scintillation cocktail. To investigate the role of NAD(P)H
oxidase in Ang II-mediated hypertrophy of proximal tubu-
lar cells, cells were replanted in 24-well plates, rested for 12
hours, and were then transfected with 1 mM of either
p22phox antisense or sense oligonucleotides using lipofec-
tin in serum-free medium. After another 12 hours, the
medium was changed, and stimulation with Ang II and
[3H]leucine pulses was performed as described above.
[3H]leucine incorporation experiments were independently
repeated five times with duplicate measurements for each
experiment.
Western blot for p27Kip1
A total of 106 quiescent cells were treated for up to 18
hours in serum-free DMEM with 1027 M Ang II in the
presence or absence of 5 to 10 mM DIP or NAC. Some cells
were also transfected with 1 mM of p22phox antisense or
sense phosphorothioate oligonucleotides as described
above. LLC-PK1 cells were also incubated with 5 to 10 mM
xanthine with or without 0.5 U/ml SOD. At the end of the
stimulation period, cells were washed twice in PBS and cell
monolayers were directly lysed on ice in 150 ml of a buffer
containing 2% SDS, 60 mM Tris-HCl (pH 6.8), 10 mM
dithiothreitol. The protein content was measured by a
modification of the Lowry method that is insensitive to the
concentrations used of SDS and dithiothreitol. Protein
concentrations were adjusted to 50 mg/sample, 5% glycerol/
0.03% bromophenol blue were added and samples were
boiled for five minutes. After centrifugation, supernatants
were loaded onto a denaturing 12% SDS-polyacrylamide
gel. Low molecular weight markers (Rainbow markersy;
Amersham), which comprise 2,350 to 45,000 Daltons,
served as the molecular weight standards. After the com-
pletion of electrophoresis, proteins were electroblotted
semi-dry for 45 minutes at 0.8 mA/cm2 to a nitrocellulose
membrane (Hybond ECL; Amersham). The blots were
blocked in 5% nonfat dry milk in PBS with 0.1% Tween 20
for one hour at room temperature. For the detection of
p27Kip1 protein, a 1:1000 dilution of a mouse monoclonal
anti-p27Kip1 antibody (Transduction Laboratories, Lexing-
ton, MA, USA) was used. Washes, incubations with horse-
radish peroxidase-conjugated anti-mouse secondary anti-
bodies and detection using the ECL reagent (Amersham)
were exactly performed as previously described [8]. Ex-
posed films from selected blots were scanned by laser
densitometry (densitometer GS 300; Hoefer Scientific In-
struments, San Francisco, CA, USA), and computer ana-
lyzed (program Gs365W). Western blots were indepen-
dently repeated three times with qualitatively similar
results.
Northern blots
To investigate whether Ang II may modulate the expres-
sion of cytochrome b-558, transcripts of p22phox were
Fig. 1. Angiotensin II (Ang II) induces O2
• generation in intact tubular
cells. Example of representative tracing of O2
• measurement using the
lucigenin method in LLC-PK1 (A) and MCT (B) cells. Cells were
stimulated with a single dose of 1027 M Ang II for four hours, and
measurement of O2
• generation was started in the luminometer after
addition of lucigenin. Emission of relative light units (RLU) was corrected
for unspecific luminescence in the absence of cells. Addition of the
cell-permeable scavenger Tiron after five minutes of recording (2)
completely inhibited chemiluminescence in control as well as Ang II-
stimulated cell. Symbols are: (M) Ang II; (f) Ang II 1 Tiron; (E) control;
(F) control 1 Tiron.
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assessed by Northern blotting. Quiescent cells were stimu-
lated for 30 minutes to four hours with a single dose of 1027
M Ang II. After being washed in RNAse-free PBS, cells
were directly lysed in 4 M guanidinium isothiocyanate, 25
mM sodium citrate (pH 7.0), 0.5% sarcosyl and 0.1 M
2-mercaptoethanol. Total RNA was isolated by repeated
phenol-chloroform extractions and isopropanol precipita-
tions. Twenty micrograms of total RNA were denatured by
heating in formamide/formaldehyde at 65°C for 20 minutes
and then electrophoresed through a 1.2% agarose gel
containing 2.2 M formaldehyde. The RNA was vacuum
blotted onto a nylon membrane (Zetabind; Cuno, Meriden,
CT, USA) and filters were UV cross-linked (Stratalinker;
Stratagene, Heidelberg, Germany). A rat p22phox cDNA
was constructed on the published rat sequence [13]. cDNA
was synthesized from 10 mg of total RNA obtained from rat
mesangial cells with 0.7 mg of poly-d(T)primer (Pharmacia-
LKB, Freiburg, Germany) in the presence of 500 units of
Moloney murine leukemia virus reverse transcriptase. A
total of 500 ng cDNA from rat mesangial cells was ampli-
fied with the polymerase chain reaction. A total of 0.15 mg of
each of the following specific rat p22phox primers were used:
59GAGTGGGCCATGTGGGCCAACG39 and 59GGATG-
GTGGCCAGCAGGAAG39. This sequence spans a sec-
tion that shows a 100% homology among rat, mouse, and
human p22phox [13]. Amplification reactions were per-
formed with the GeneAmpy kit (Perkin Elmer Cetus,
U¨berlingen, Germany) for a total of 40 cycles using an
annealing temperature of 42°C for 1.5 minutes, an exten-
sion step at 72°C for 1.5 minutes and a denaturation step at
92°C for 1.5 minutes. Agarose gel electrophoresis revealed
a single band exactly of the predicted 314 bp, and this
amplification product was subcloned into the pCRII vector
(Invitrogen, San Diego, CA, USA). Sequencing with the
dideoxy chain termination method revealed that the ampli-
fied cDNA was identical to the reported sequence for rat
p22phox [13]. The cDNA insert was labeled with
[32P]dATP (3,000 Ci/mmol, Amersham) using hexamer
primers. Prehybridization, hybridization, washes, and auto-
radiography were performed as previously described in
detail [12]. To control for small variations in RNA loading
and transfer, stripped filters were rehybridized with a 2.0 kb
cDNA insert of the plasmid pMCI encoding the murine
ribosomal 18 S band. Exposed films were scanned by laser
densitometry. Northern blots were independently (separate
stimulation, RNA isolation, and hybridization) performed
three times with qualitatively similar results.
Statistical analysis
Results are expressed as means 6 SEM. Statistical signif-
icance of differences among all groups was first tested with
the nonparametric Kruskal-Wallis test for multiple sample
comparison. If this test was significant, individual samples
were compared using the Wilcoxon-Mann-Whitney test. A
P value of ,0.05 was considered significant.
RESULTS
Superoxide anion production in intact cells
Stimulation of MCT and LLC-PK1 cells with a single
dose of 1027 M Ang II led to a significant increase in O2
•
Fig. 2. Northern blot for p22phox. LLC-PK1 cells were either incubated
in serum-free control medium or challenged with a single dose of 1027 M
Ang II. Ang II significantly stimulated p22phox expression after 2 to 4
hours compared to controls. This blot is representative of three indepen-
dent experiments. Similar results were obtained with MCT cells (data not
shown).
Table 1. Superoxide production in intact tubular cells
LLC-PK1 cells MCT cells
Controls 45 6 3 62 6 4
Controls 1 1026 M Los 38 6 4 65 6 8
Controls 1 1026 M PD 41 6 2 70 6 9
Controls 1 5 mM DIP 43 6 2 75 6 3
Controls 1 10 mM DIP 52 6 2 60 6 2
Controls 1 1 mM NAC 49 6 3 63 6 9
Controls 1 10 mM NAC 54 6 3 47 6 3a
1027 M Ang II 96 6 8a 160 6 31a
1027 M Ang II 1 1026 M Los 59 6 6b 83 6 9b
1027 M Ang II 1 1026 M PD 96 6 5a 181 6 88a
1027 M Ang II 1 5 mM DIP 60 6 1b 107 6 8b
1027 M Ang II 1 10m M DIP 58 6 3b 47 6 b
1027 M Ang II 1 1 mM NAC 60 6 4b 93 6 36
1027 M Ang II 1 10 mM NAC 64 6 3b 75 6 15b
Controls 1 p22phox sense 68 6 10a 58 6 4
1027 M Ang II 1 p22phox sense 158 6 26c 107 6 9c
Controls 1 p22phox antisense 80 6 9* 50 6 4
1027 M Ang II 1 p22phox antisense 102 6 17d 65 6 4d
Data are nM O2zmin/5310
6 cells, N 5 4–7, controls 1 mediators: N 5
2–3.
a P , 0.01 vs. controls.
b P , 0.01 vs. Ang II only.
c P , 0.05 vs. controls 1 sense.
d P , 0.05 vs. Ang II 1 sense.
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production as measured with the lugenin method. A typical
tracing of one representative experiment is shown in Figure
1. Addition of 10 mM Tiron, a nonenzymatic O2
• scavenger,
almost completely reduced the emission of photons in
control as well as Ang II-stimulated cells, indicating the
specificity of the lucigenin assay system (Fig. 1). Amounts
of O2
• concentrations were obtained by comparison with a
standard curve generated by using xanthine/xanthine oxi-
dase and are given in Table 1. The Ang II-stimulated
induction of O2
• was mediated by AT1-receptors because it
could be totally blocked by losartan, but not with an
AT2-receptor antagonist (Table 1). The flavoprotein inhib-
itor DIP, in two different concentrations, also significantly
attenuated Ang II-induced O2
• production, but had no
effect on basal formation in unstimulated control cells
(Table 1). Furthermore, the addition of the antioxidant
NAC, five minutes before starting the measurements, also
significantly reduced the measurable amount of O2
• in Ang
II-stimulated cells, but also reduced in the higher dose, as
expected, the detectable basal generation of oxygen metab-
olites in control cells (Table 1).
Since it has been previously demonstrated in VSMC that
up-regulation of p22phox is a pivotal mechanism for mem-
brane NAD(P)H oxidase activation [9], cells were tran-
siently transfected with 1 mM of phosphorothioate-modified
p22phox sense or antisense oligonucleotides. As shown in
Table 1, unstimulated cells after transfection with either
sense or antisense p22phox oligonucleotides released more
O2
• compared with untransfected cells, indicating that the
transfection process involving liposomes itself may stimu-
late basal generation of oxygen metabolites. However,
transfection with antisense, but not sense, p22phox oligo-
nucleotides significantly reduced Ang II-induced O2
• gen-
eration, suggesting that NAD(P)H oxidase is important in
this process (Table 1).
Angiotensin II-stimulated induction of p22phox, a
subunit of NAD(P)H oxidase
Since the flavoprotein inhibitor DIP significantly reduced
the Ang II-stimulated superoxide anion generation in both
cell lines, it is likely that this O2
• production occurs via
membrane NAD(P)H oxidase activation. It has been pre-
viously demonstrated that Ang II stimulates expression of
p22phox in VSMC [9]. Consequently, we tested whether
similar mechanisms may be operative in tubular cells. As in
the example shown with LLC-PK1 cells in Figure 2, a single
dose of 1027 M Ang II for two to four hours significantly
stimulated p22phox mRNA expression (controls 30 min,
100 6 8; Ang II 30 min, 105 6 8; controls 2 hr, 100 6 5;
Ang II 2 hr, 185 6 12*; controls 4 hr, 100 6 10; Ang II 4 hr,
220 6 15*; relative changes in mRNA expression; *P ,
0.05, N 5 3 independent experiments). A similar induction
of p22phox transcripts was observed in Ang II-treated
MCT cells (data not shown).
Interference with angiotensin II-induced superoxide
formation abolishes cellular hypertrophy
To investigate whether the Ang II-stimulated O2
• syn-
thesis is essential for the subsequent induction of tubular
hypertrophy, different approaches were applied to interfere
Fig. 3. [3H]leucine incorporation into de novo
synthesized proteins of LLC-PK1 cells as a
parameter for hypertrophy. Cells were
stimulated with 1027 Ang II (f) or treated with
control medium (M) for 24 hours. The
flavoprotein inhibitor DIP as well as the
antioxidant NAC completely abolished Ang II-
mediated increase in [3H]leucine incorporation,
but had no effect on basal protein synthesis in
unstimulated controls. N 5 6 independent
experiments, *P , 0.01 versus controls, #P ,
0.01 versus cells treated with Ang II only.
Table 2. Effect of transient transfection of tubular cells with p22phox
antisense or sense oligonucleotides on Ang II-stimulated protein
synthesis
LLC-PK 1 cells MCT cells
Controls 1 sense 5203 6 326 2561 6 451
1027 M Ang II 1 sense 8834 6 803a 4361 6 397a
Controls 1 antisense 4726 6 624 2653 6 323
1027 M Ang II 1 antisense 5960 6 509 2341 6 241
cpm, a P , 0.05 versus Ang II 1 sense, N 5 4–6
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with O2
• generation. We used incorporation of [3H]leucine
into de novo synthesized proteins as a measurement of
cellular hypertrophy for this study, and we have previously
demonstrated in several studies that this parameter closely
correlates with hypertrophy in tubular cells [3, 4, 12]. As
shown in Figure 3, the flavoprotein inhibitor DIP as well as
the antioxidants NAC totally abolished the Ang II-stimu-
lated [3H]leucine incorporation in newly synthesized pro-
teins of LLC-PK1 cells. However, DIP and NAC had no
significant influence on protein synthesis in unstimulated
cells indicating that the concentrations used were not toxic
(Fig. 3). Similar results were obtained with MCT cells (data
not shown).
To further examine whether NAD(P)H oxidase expres-
sion is essential for Ang II-mediated hypertrophy, we used
antisense phosphorothioate-modified p22 phox antisense
oligonucleotides to transiently suppress cytochrome b-558
activity. As demonstrated in Table 2, transient transfection
of LLC-PK1 as well as MCT cells with 1 mM of p22phox
antisense, but not sense, oligonucleotides partly abolished
the Ang II-stimulated de novo protein synthesis in both cell
lines as measured by [3H]leucine incorporation.
Interference with angiotensin II-mediated superoxide
anion production attenuated p27Kip1 expression
We have previously shown that induction of the CdK-
inhibitor p27Kip1 is essential for Ang II-induced cell cycle
arrest and hypertrophy of LLC-PK1 cells [8]. Therefore, we
tested whether interference with Ang II-stimulated O2
•
production may influence protein expression of p27Kip1. As
demonstrated in Figure 4, 5 to 10 mM DIP totally abolished
the Ang II-stimulated p27Kip1 protein expression in LLC-
PK1 cells (controls, 100 6 15; controls 1 5 mM DIP, 93 6
12; controls 1 10 mM DIP, 103 6 13; Ang II, 230 6 8*; Ang
II 1 5 mM DIP, 115 6 22#; Ang II 1 10 mM DIP, 80 6 19#;
relative changes in p27Kip1 expression; *P , 0.05 vs.
controls, #P , 0.05 vs. Ang II alone, N 5 3 independent
experiments). This flavoprotein inhibitor also abolished
Ang II-mediated p27Kip1 accumulation in MCT cells (data
not shown). In addition, the antioxidant NAC also attenu-
ated Ang II-induced p27Kip1 protein expression in MCT
cells (Fig. 5; controls, 100 6 8; controls 1 5 mM NAC,
140 6 24; controls 1 10 mM NAC, 120 6 25; Ang II, 420 6
30*; Ang II 1 5 mM NAC, 350 6 26; Ang II 1 10 mM NAC,
150 6 21#; relative changes in p27Kip1 expression; *P ,
Fig. 4. Western blot for p27Kip1 protein. LLC-
PK1 cells were stimulated for 18 hours with
1027 M Ang II in the presence of absence of 5
to 10 mM of the flavoprotein inhibitor DIP. As
predicted, Ang II-treatment induced p27Kip1
protein expression. This induction was
attenuated by DIP, but the flavoprotein
inhibitor did not influence basal p27Kip1
expression. This blot is representative for three
independent experiments with qualitatively
similar results.
Fig. 5. Western blot for p27Kip1 protein. The
effect of the antioxidant NAC on Ang II-
stimulated p27Kip1 protein expression was tested
in MCT cells. Cells were incubated for 18
hours. In particular, the higher concentration of
NAC (10 mM) partly attenuated Ang II-induced
p27Kip1 protein expression. This blot is
representative for three independent
experiments with qualitatively similar results.
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0.05 vs. controls, #P , 0.05 vs. Ang II alone, N 5 3
independent experiments). A similar reduction of Ang
II-stimulated p27Kip1 expression by NAC was observed in
LLC-PK1 cells (data not shown). Moreover, Ang II-in-
duced p27Kip1 expression was completely reduced in the
presence of 10 mM Tiron in both cell lines (data not shown).
Pretreatment of cells with p22phox antisense oligonucle-
otides attenuated the subsequent Ang II-mediated induc-
tion of p27Kip1 in both cell lines (Fig. 6). This effect was
stronger in LLC-PK1 cells compared with MCT cells (Fig.
6). However, transient transfection of control cells with
antisense oligonucleotides occasionally induced p27Kip1
protein in the absence of Ang II, indicating that the
liposomes and/or antisense oligonucleotides used may in-
fluence the basal expression of cell cycle regulatory pro-
teins.
Active oxygen species generated by other enzyme systems
also induce p27Kip1 expression
To test whether oxygen species independently generated
from Ang II stimulation may also influence p27Kip1 protein
expression, LLC-PK1 cells were supplemented for four
hours with 5 to 10 mM xanthine. This dose stimulated a
significant increase in O2
• as measured by the lucigenin
method. However, this stimulation was not reduced in the
presence of 0.5 units/ml SOD (controls, 69 6 8; 5 mM
xanthine, 138 6 40*; 10 mM xanthine, 123 6 30*; 5 mM
xanthine 6 SOD, 289 6 74*; 10 mM xanthine 1 SOD,
167 6 12.5*; nM O2
•/min/5 3 106 cells, P , 0.05, N 5 3).
Supplementation of serum-free medium with exogenous
xanthine for 18 hours also stimulated cellular hypertrophy
of LLC-PK1 cells as measured by de novo protein synthesis
(controls, 3238 6 250; 1 mM, 4084 6 178*; 5 mM, 4200 6
108#; 10 mM, 4023 6 63# cpm; N 5 5, *P , 0.05 vs.
controls, #P , 0.01 vs. controls). Figure 7 shows that an
addition of 5 to 10 mM xanthine to quiescent LLC-PK1 cells
also stimulated a significant increase in p27Kip1 expression,
suggesting that active oxygen species generated by sources
other than membrane bound oxidases can also interfere
with the expression of cell cycle regulatory proteins.
DISCUSSION
We and others have previously demonstrated that Ang II
stimulates hypertrophy of cultured proximal tubular cells
including LLC-PK1 and MCT cells [3–7]. More recently we
investigated the molecular mechanisms underlying this
hypertrophy and discovered that G1-phase arrest caused by
p27Kip1 expression plays a pivotal role in Ang II-mediated
hypertrophy [8]. Although earlier studies suggest that a
decrease in intracellular cAMP may be involved in Ang
II-stimulated hypertrophy of tubular cells [12], the exact
signal transduction pathways of how Ang II causes cell cyle
arrest are unknown. Since it has been demonstrated in
VSMC that Ang II induces reactive oxygen species [9] and
that the concomitant hypertrophy may also depend on this
mechanism, we investigated whether similar mechanisms
are operative in tubular cells.
Our data collectively suggest that a single dose of Ang II
readily stimulates the formation of O2
• in LLC-PK1 as well
as MCT cells. This effect was transduced through AT1-
receptors and depended on activation of membrane
NAD(P)H oxidase, because a flavoprotein inhibitor (DIP)
as well as p22phox antisense oligonucleotide treatment
abolished the Ang II-induced accumulation of O2
•. In the
present study we relied on the widely used lucigenin
method to measure the intracellular production of reactive
oxygen species [14–17]. The chemical specificity of the
lucigenin assay for O2
• was confirmed using the nonenzy-
matic scavenger Tiron. The inhibition of Ang II-stimulated
superoxide anion production by DIP and the attenuation of
the response in cells transiently transfected with p22phox
Fig. 6. Effect of p22phox antisense oligonucleotides on Ang II-induced
p27Kip1 protein expression in LLC-PK1 (A) and MCT (B) cells. Western
blot. Quiescent cells were transiently transfected with either 1 mM p22phox
sense or antisense phosphorothioate oligonucleotides using liposomes.
p22phox antisense treatment almost completely abolished the Ang II-
mediated stimulation of p27Kip1 expression. This effect was somewhat
stronger in LLC-PK1 cells (panel A) compared with MCT cells (panel B).
Interestingly, transient transfection of control cells with p22phox sense
oligonucleotides induced basal p27Kip1 expression. This blot is represen-
tative for three independent experiments with qualitatively similar results.
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antisense oligonucleotides provides good evidence that,
indeed, the membrane-bound multienzyme complex
NAD(P)H oxidase [18] is involved in this Ang II-mediated
process.
Cell associated O2
• production has been mainly de-
scribed as a specific function of phagocytic cells [18].
However, a recent study clearly suggests that other cells,
such as VSMC and fibroblasts, express membrane
NAD(P)H oxidase [18]. In the kidney, subunits of this
multienzyme complex have been localized in mesangial
cells [19] and podocytes [20]. It has been demonstrated that
Ang II stimulates production through the membrane
NAD(P)H oxidase pathway in cultured VSMC as well as in
the vascular bed in vivo of rats after infusion of Ang II [9,
21–23]. Although it has been previously demonstrated in
VSMC that Ang II induces the generation of O2
•, our study
is, to the best of our knowledge, the first showing a similar
effect in renal tubular cells. Inhibition of p22phox expres-
sion in VSMC by stable transfection of antisense cDNA
abolished Ang II-stimulated O2
• production [24]. Further-
more, Ang II-mediated, but not catecholamine-induced,
hypertension in rats depends on the generation of O2
•,
likely via degradation of vasorelaxant nitrogen monoxide,
because infusion of SOD decreased the elevated blood
pressure in Ang II-infused animals [22]. Since Ang II
increased p22phox transcripts in tubular cells and interfer-
ence with NAD(P)H oxidase activation (for example with
DIP or p22phox antisense oligonucleotides) abolished Ang
II-mediated O2
• production, we believe, in analogy to data
obtained from VSMC [24], that an Ang II-induced increase
in p22phox expression, one of the key electron transfer
elements of the multienzyme NAD(P)H oxidase complex,
is pivotal in stimulated O2
• generation in proximal tubular
cells [18].
An important role of reactive oxygen species in growth
has been described in several cell types. For example,
xanthine and xanthine oxidase treatment of VSMC stimu-
lated proliferation and induction of the immediate early
genes c-my and c-fos [25]. Furthermore, exogenous hydro-
gen peroxide also induces c-fos and c-jun in these cells [26,
27]. Generation of O2
• by prolonged auto-oxidation of
hydrazine derivatives induced proliferation of cultured
mouse fibroblasts [28]. However, in addition to this prolif-
erative effect of O2
• forced onto cells by exogenous manip-
ulation, it has been recently described that oxygen species
may also act as second messengers transducing growth
stimulatory effects to the nucleus. Irani and co-workers
have recently demonstrated that reactive oxygen species,
probably O2
•, are intracellular mediators of ras-induced
cell cycle progression of 3T3 fibroblasts [29]. Moreover,
growth responses other than proliferation such as hyper-
trophy may be also mediated by reactive oxygen species.
Ushio-Fukai and co-workers provided compelling evidence
that the Ang II-mediated hypertrophy of VSMC depends
on O2
•, produced by the NAD(P)H oxidase system [24].
However, the molecular mechanism of this O2
•-mediated
hypertrophy has not been further characterized.
Our present study demonstrates that Ang II-mediated
O2
• generation leads to the expression of p27Kip1 and
subsequent hypertrophy of LLC-PK1 and MCT cells be-
cause interference with this stimulated expression of reac-
tive oxygen species by various means abolished p27Kip1
expression and hypertrophy. We have previously shown
that Ang II-mediated p27Kip1 expression depends on a
post-transcriptional mechanisms and is essential for the
G1-phase arrest of tubular cells and subsequent hypertro-
phy [8]. We propose a signal transduction mechanism
outlined in Figure 8: Ang II, after binding to AT1-recep-
tors, stimulates mRNA expression of p22phox and there-
fore up-regulation of NAD(P)H oxidase activity. The in-
crease in O2
• formation then induces p27Kip1 expression
either directly or indirectly, ultimately leading to G1-phase
arrest and hypertrophy. How the Ang II-mediated increase
in O2
• induces p27Kip1 protein expression is currently
unclear, but a few suggestions can be made. A central role
of the ubiquitin-proteasome pathway in regulating p27Kip1
Fig. 7. Generation of O2
• by xanthine/xanthine
oxidase also stimulates p27Kip1 expression in
LLC-PK1 cells. Western blot. Quiescent cells
were incubated in serum-free medium for 18
hours with 5 to 10 mM xanthine or 1027 M Ang
II. The p27Kip1 protein expression induced by
10 mM xanthine was even stronger compared
with 1027 M Ang II. Co-incubation with 0.5
units/ml SOD had no effect on xanthine-
mediated p27Kip1 expression. This blot is
representative of three independent
experiments with qualitatively similar results.
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abundance has been described in human osteosarcoma
cells [30]. A phosphorylation of p27Kip1 is a necessary
prerequisite in order to be degraded by the proteasome [31,
32]. It is possible that Ang II-induced reactive oxygen
species may interfere with the multiple steps of p27Kip1
phosphorylation and ubiquitination, resulting in an inhibi-
tion of proteolysis and a concomitant increase in p27Kip1
protein levels. Alternatively, p27Kip1 could be increased
through an enhanced translation of the protein [31, 33]. On
the other hand, we cannot exclude that induction of
transforming growth factor beta (TGF-b) transcription
[12], for example through O2
•-mediated activation and
nuclear translocation of NF-kB, may play a role in the
increased expression of p27Kip1. Further studies are re-
quired to define the molecular mechanisms of how an
increase in intracellular O2
• finally leads to enhanced
p27Kip1 expression.
Interestingly, O2
•-induced expression of CdK-inhibitors
such as p27Kip1 is not restricted to the kidney, but may be a
more common phenomena occurring in other cell types. It
has been shown in cultured lung alveolar epithelial cells
that exposure to hyperoxia that stimulates O2
• accumula-
tion induces p21 [34], another CdK-inhibitor an important
effector of the growth suppressive function of p53 [35, 36].
Our xanthine supplementation data clearly suggest that
generation of O2
• by other enzymatic systems independent
of Ang II and NAD(P)H oxidase also stimulates p27Kip1
expression and tubular hypertrophy. Co-incubation of
LLC-PK1 cells with SOD in a concentration reducing
generation in the cell-free xanthine/xanthine oxidase sys-
tem failed to abolished xanthine-mediated production and
p27Kip1 expression in LLC-PK1 cells. Although this suggests
that other active species such hydrogen peroxide mediate
these processes, a more likely explanation is the potential
failure of sufficient cellular SOD uptake because in vivo
models have convincingly shown that SOD must be manip-
ulated, for example, as basic peptide fusion protein or
encapsulated into liposomes, for effective transcellular
transport [22, 37]. Nevertheless, the observation that O2
•-
mediated p27Kip1 expression and hypertrophy is not limited
to the membrane NAD(P)H oxidase system may have
important pathophysiological implications because reactive
oxygen species are produced in the kidney during a variety
of diseases [reviewed in 38–42]. An intriguing possibility is
that such processes, for example O2
• release through the
respiratory burst of neutrophils recruited into the tubu-
lointerstitium during tubulointerstitial inflammation, may
locally influence growth processes such as hypertrophy of
adjacent tubular cells. Furthermore, reperfusion after renal
ischemia generates O2
•, which may inhibit the G1-S-phase
transition of tubular cells, a potentially detrimental effect
because proliferation of surviving cells is important in
repopulating the injured nephron after tubular necrosis
[43]. In fact, an increase in p21 expression, albeit localized
to cells of the thick ascending limb and distal convoluted
tubules, has been found in different animal models of acute
renal failure [44].
The landmark studies by Nath and colleagues demon-
strating that a diet deficient in vitamin E and selenium
induces glomerular and tubular hypertrophy in naive rats
suggest that reactive oxygen species may modulate renal
growth in vivo [45, 46]. Animals fed this prooxidant diet
exhibit increased renal mitochondrial generation of hydro-
gen peroxide [46]. Thus, generation of O2
• by various
Fig. 8. Proposed signal transduction pathways of how Ang II may
stimulate p27Kip1 expression. After binding to AT1-receptors, Ang II leads
to an increase in p22phox expression. An increase in this subunit may
activate enzyme activity of the membrane-bound NAD(P)H oxidase. This
leads to the formation of O2
•, which in turn increases the protein
expression of p27Kip1. Ultimately, p27Kip1 binds to G1-phase CdK-cyclin
complexes, inhibits their kinase activities, and induces G1-phase arrest
leading to cellular hypertrophy. How exactly O2
• stimulates p27Kip1
expression is currently unknown. Inhibition of protein degradation, stim-
ulation of translational activity, or, alternatively, O2
•-mediated TGF-b
expression could all be potential mechanisms.
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enzymatic systems could be a common denominator how
different pathophysiological stimuli may stimulate tubular
hypertrophy in concert with the subsequent development of
tubulointerstitial injury.
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APPENDIX
Abbreviations used in this article are: Ang, angiotensin; AT1, angioten-
sin receptor type-1; CdK, cyclin-dependent kinase; DIP, diphenylene
iodinium; DMEM, Dulbecco’s modified Eagle’s medium; LLC-PK1, por-
cine cell line; MCT, cultured mouse proximal tubule; NAC, N-acetylcys-
teine; NAD(P)H, nicotinamide adenine dinucleotide phosphate; O2
•,
superoxide anions; SOD, superoxide dismutase; TGF-b, transforming
growth factor-b; VSMC, vascular smooth muscle cells.
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